The North America Sacral Nerve Stimulation Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030).
To administer regulated electrical stimulation to the sacral nerves, a tiny device known as a neurostimulator is implanted beneath the skin during sacral nerve stimulation therapy. The control of bowel and bladder function depends on these nerves. With electrodes close to the sacral nerves, the neurostimulator can modify nerve activity and alleviate symptoms of disorders like urine and fecal incontinence.
Increased incidences of urological disorders like chronic anal fissure, urinary & fecal incontinence, and overactive bladder syndrome, an upsurge in the population's average age, technological advancements, and increased public awareness of the market are the main factors propelling the market's growth. For instance, research from the American Urological Association states that one-third of men and women in the US experience urine incontinence. Thirty-three million people have an overactive bladder, which can cause urgency sensations. Because sacral nerve stimulation is a successful treatment for urological incontinence, the prevalence of this ailment is increasing, boosting the need for it.
Increased prevalence of overactive bladder (OAB) and urge incontinence, increased knowledge of available treatments, and rising use of technologically advanced medical devices, including implantable sacral nerve stimulation (SNS) devices, are all expected to contribute to the market growth in North America. As a result, the high rate of diabetes in the American population is also accompanied by a significant rate of urinary tract infections (UTIs), which raises the demand for surgical operations and fuels the market's expansion. As a result, the rising incidence of urine incontinence in the region will probably be one of the key elements influencing the market under study during the coming years.
The US market dominated the North America Sacral Nerve Stimulation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $159.9 Million by 2030. The Canada market is poised to grow at a CAGR of 6.8% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 5.9% during (2023 - 2030).
Based on Application, the market is segmented into Urinary & Fecal Incontinence, Chronic Anal Fissure, and Others. Based on Product, the market is segmented into Devices, and Accessories. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Sacral Nerve Stimulation Market is Projected to reach USD 595.9 Million by 2030, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Axonics, Inc., Beijing PINS Medical Co., Ltd., PZMed, Laborie Medical Technologies, Synapse BioMedical, Inc., Johnson and Johnson, LivaNova PLC, Boston Scientific Corporation, and Saluda Medical Pty Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Urinary & Fecal Incontinence
- Chronic Anal Fissure
- Others
By Product
By End User
- Hospitals
- Specialty Clinics
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Axonics, Inc.
- Beijing PINS Medical Co., Ltd.
- PZMed
- Laborie Medical Technologies
- Synapse BioMedical, Inc.
- Johnson and Johnson
- LivaNova PLC
- Boston Scientific Corporation
- Saluda Medical Pty Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sacral Nerve Stimulation Market, by Application
1.4.2 North America Sacral Nerve Stimulation Market, by Product
1.4.3 North America Sacral Nerve Stimulation Market, by End User
1.4.4 North America Sacral Nerve Stimulation Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. North America Sacral Nerve Stimulation Market by Application
4.1 North America Urinary & Fecal Incontinence Market by Country
4.2 North America Chronic Anal Fissure Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Sacral Nerve Stimulation Market by Product
5.1 North America Devices Market by Country
5.2 North America Accessories Market by Country
Chapter 6. North America Sacral Nerve Stimulation Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Specialty Clinics Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Sacral Nerve Stimulation Market by Country
7.1 US Sacral Nerve Stimulation Market
7.1.1 US Sacral Nerve Stimulation Market by Application
7.1.2 US Sacral Nerve Stimulation Market by Product
7.1.3 US Sacral Nerve Stimulation Market by End User
7.2 Canada Sacral Nerve Stimulation Market
7.2.1 Canada Sacral Nerve Stimulation Market by Application
7.2.2 Canada Sacral Nerve Stimulation Market by Product
7.2.3 Canada Sacral Nerve Stimulation Market by End User
7.3 Mexico Sacral Nerve Stimulation Market
7.3.1 Mexico Sacral Nerve Stimulation Market by Application
7.3.2 Mexico Sacral Nerve Stimulation Market by Product
7.3.3 Mexico Sacral Nerve Stimulation Market by End User
7.4 Rest of North America Sacral Nerve Stimulation Market
7.4.1 Rest of North America Sacral Nerve Stimulation Market by Application
7.4.2 Rest of North America Sacral Nerve Stimulation Market by Product
7.4.3 Rest of North America Sacral Nerve Stimulation Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Trials and Approvals:
8.1.6 SWOT Analysis
8.2 Axonics, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Product and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals:
8.2.6 SWOT Analysis
8.3 Beijing PINS Medical Co., Ltd.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 Saluda Medical Pty Ltd.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 PZMed
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 LivaNova PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Boston Scientific Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Johnson & Johnson
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Synapse BioMedical, Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Laborie Medical Technologies (Patricia Industries) (Investor AB)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis
TABLE 1 North America Sacral Nerve Stimulation Market, 2019 - 2022, USD Thousand
TABLE 2 North America Sacral Nerve Stimulation Market, 2023 - 2030, USD Thousand
TABLE 3 North America Sacral Nerve Stimulation Market by Application, 2019 - 2022, USD Thousand
TABLE 4 North America Sacral Nerve Stimulation Market by Application, 2023 - 2030, USD Thousand
TABLE 5 North America Urinary & Fecal Incontinence Market by Country, 2019 - 2022, USD Thousand
TABLE 6 North America Urinary & Fecal Incontinence Market by Country, 2023 - 2030, USD Thousand
TABLE 7 North America Chronic Anal Fissure Market by Country, 2019 - 2022, USD Thousand
TABLE 8 North America Chronic Anal Fissure Market by Country, 2023 - 2030, USD Thousand
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Thousand
TABLE 10 North America Others Market by Country, 2023 - 2030, USD Thousand
TABLE 11 North America Sacral Nerve Stimulation Market by Product, 2019 - 2022, USD Thousand
TABLE 12 North America Sacral Nerve Stimulation Market by Product, 2023 - 2030, USD Thousand
TABLE 13 North America Devices Market by Country, 2019 - 2022, USD Thousand
TABLE 14 North America Devices Market by Country, 2023 - 2030, USD Thousand
TABLE 15 North America Accessories Market by Country, 2019 - 2022, USD Thousand
TABLE 16 North America Accessories Market by Country, 2023 - 2030, USD Thousand
TABLE 17 North America Sacral Nerve Stimulation Market by End User, 2019 - 2022, USD Thousand
TABLE 18 North America Sacral Nerve Stimulation Market by End User, 2023 - 2030, USD Thousand
TABLE 19 North America Hospitals Market by Country, 2019 - 2022, USD Thousand
TABLE 20 North America Hospitals Market by Country, 2023 - 2030, USD Thousand
TABLE 21 North America Specialty Clinics Market by Country, 2019 - 2022, USD Thousand
TABLE 22 North America Specialty Clinics Market by Country, 2023 - 2030, USD Thousand
TABLE 23 North America Others Market by Country, 2019 - 2022, USD Thousand
TABLE 24 North America Others Market by Country, 2023 - 2030, USD Thousand
TABLE 25 North America Sacral Nerve Stimulation Market by Country, 2019 - 2022, USD Thousand
TABLE 26 North America Sacral Nerve Stimulation Market by Country, 2023 - 2030, USD Thousand
TABLE 27 US Sacral Nerve Stimulation Market, 2019 - 2022, USD Thousand
TABLE 28 US Sacral Nerve Stimulation Market, 2023 - 2030, USD Thousand
TABLE 29 US Sacral Nerve Stimulation Market by Application, 2019 - 2022, USD Thousand
TABLE 30 US Sacral Nerve Stimulation Market by Application, 2023 - 2030, USD Thousand
TABLE 31 US Sacral Nerve Stimulation Market by Product, 2019 - 2022, USD Thousand
TABLE 32 US Sacral Nerve Stimulation Market by Product, 2023 - 2030, USD Thousand
TABLE 33 US Sacral Nerve Stimulation Market by End User, 2019 - 2022, USD Thousand
TABLE 34 US Sacral Nerve Stimulation Market by End User, 2023 - 2030, USD Thousand
TABLE 35 Canada Sacral Nerve Stimulation Market, 2019 - 2022, USD Thousand
TABLE 36 Canada Sacral Nerve Stimulation Market, 2023 - 2030, USD Thousand
TABLE 37 Canada Sacral Nerve Stimulation Market by Application, 2019 - 2022, USD Thousand
TABLE 38 Canada Sacral Nerve Stimulation Market by Application, 2023 - 2030, USD Thousand
TABLE 39 Canada Sacral Nerve Stimulation Market by Product, 2019 - 2022, USD Thousand
TABLE 40 Canada Sacral Nerve Stimulation Market by Product, 2023 - 2030, USD Thousand
TABLE 41 Canada Sacral Nerve Stimulation Market by End User, 2019 - 2022, USD Thousand
TABLE 42 Canada Sacral Nerve Stimulation Market by End User, 2023 - 2030, USD Thousand
TABLE 43 Mexico Sacral Nerve Stimulation Market, 2019 - 2022, USD Thousand
TABLE 44 Mexico Sacral Nerve Stimulation Market, 2023 - 2030, USD Thousand
TABLE 45 Mexico Sacral Nerve Stimulation Market by Application, 2019 - 2022, USD Thousand
TABLE 46 Mexico Sacral Nerve Stimulation Market by Application, 2023 - 2030, USD Thousand
TABLE 47 Mexico Sacral Nerve Stimulation Market by Product, 2019 - 2022, USD Thousand
TABLE 48 Mexico Sacral Nerve Stimulation Market by Product, 2023 - 2030, USD Thousand
TABLE 49 Mexico Sacral Nerve Stimulation Market by End User, 2019 - 2022, USD Thousand
TABLE 50 Mexico Sacral Nerve Stimulation Market by End User, 2023 - 2030, USD Thousand
TABLE 51 Rest of North America Sacral Nerve Stimulation Market, 2019 - 2022, USD Thousand
TABLE 52 Rest of North America Sacral Nerve Stimulation Market, 2023 - 2030, USD Thousand
TABLE 53 Rest of North America Sacral Nerve Stimulation Market by Application, 2019 - 2022, USD Thousand
TABLE 54 Rest of North America Sacral Nerve Stimulation Market by Application, 2023 - 2030, USD Thousand
TABLE 55 Rest of North America Sacral Nerve Stimulation Market by Product, 2019 - 2022, USD Thousand
TABLE 56 Rest of North America Sacral Nerve Stimulation Market by Product, 2023 - 2030, USD Thousand
TABLE 57 Rest of North America Sacral Nerve Stimulation Market by End User, 2019 - 2022, USD Thousand
TABLE 58 Rest of North America Sacral Nerve Stimulation Market by End User, 2023 - 2030, USD Thousand
TABLE 59 Key Information – Medtronic PLC
TABLE 60 Key Information – Axonics, Inc.
TABLE 61 Key Information – Beijing PINS Medical Co., Ltd.
TABLE 62 key information – Saluda Medical Pty Ltd.
TABLE 63 Key Information – PZMed
TABLE 64 Key Information – LivaNova PLC
TABLE 65 Key Information – Boston Scientific Corporation
TABLE 66 Key Information – Johnson & Johnson
TABLE 67 Key Information – Synapse BioMedical, Inc.
TABLE 68 Key Information – Laborie Medical Technologies
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Sacral Nerve Stimulation Market, 2019 - 2030, USD Thousand
FIG 3 Key Impacting Factors Sacral Nerve Stimulation Market
FIG 4 Porter’s Five Force Analysis: Sacral Nerve Stimulation Market
FIG 5 North America Sacral Nerve Stimulation Market share by Application, 2022
FIG 6 North America Sacral Nerve Stimulation Market share by Application, 2030
FIG 7 North America Sacral Nerve Stimulation Market by Application, 2019 - 2030, USD Thousand
FIG 8 North America Sacral Nerve Stimulation Market share by Product, 2022
FIG 9 North America Sacral Nerve Stimulation Market share by Product, 2030
FIG 10 North America Sacral Nerve Stimulation Market by Product, 2019 - 2030, USD Thousand
FIG 11 North America Sacral Nerve Stimulation Market share by End User, 2022
FIG 12 North America Sacral Nerve Stimulation Market share by End User, 2030
FIG 13 North America Sacral Nerve Stimulation Market by End User, 2019 - 2030, USD Thousand
FIG 14 North America Sacral Nerve Stimulation Market share by Country, 2022
FIG 15 North America Sacral Nerve Stimulation Market share by Country, 2030
FIG 16 North America Sacral Nerve Stimulation Market by Country, 2019 - 2030, USD Thousand
FIG 17 SWOT Analysis: Medtronic PLC
FIG 18 SWOT Analysis: Axonics, Inc.
FIG 19 SWOT Analysis: BEIJING PINS MEDICAL CO., LTD.
FIG 20 SWOT Analysis: Saluda Medical Pty Ltd.
FIG 21 SWOT Analysis: PZMed
FIG 22 SWOT Analysis: LivaNova PLC
FIG 23 SWOT Analysis: Boston Scientific Corporation
FIG 24 Swot Analysis: Johnson & Johnson
FIG 25 SWOT Analysis: Synapse BioMedical, Inc.
FIG 26 SWOT Analysis: Laborie Medical Technologies